Structural basis for the inhibition of tyrosine kinase activity of ZAP-70. 2007

Sebastian Deindl, and Theresa A Kadlecek, and Tomas Brdicka, and Xiaoxian Cao, and Arthur Weiss, and John Kuriyan
Department of Molecular and Cell Biology, Department of Chemistry, and Howard Hughes Medical Institute, University of California, Berkeley, CA 94720, USA.

ZAP-70, a cytoplasmic tyrosine kinase required for T cell antigen receptor signaling, is controlled by a regulatory segment that includes a tandem SH2 unit responsible for binding to immunoreceptor tyrosine-based activation motifs (ITAMs). The crystal structure of autoinhibited ZAP-70 reveals that the inactive kinase domain adopts a conformation similar to that of cyclin-dependent kinases and Src kinases. The autoinhibitory mechanism of ZAP-70 is, however, distinct and involves interactions between the regulatory segment and the hinge region of the kinase domain that reduce its flexibility. Two tyrosine residues in the SH2-kinase linker that activate ZAP-70 when phosphorylated are involved in aromatic-aromatic interactions that connect the linker to the kinase domain. These interactions are inconsistent with ITAM binding, suggesting that destabilization of this autoinhibited ZAP-70 conformation is the first step in kinase activation.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D004794 Enzyme Repression The interference in synthesis of an enzyme due to the elevated level of an effector substance, usually a metabolite, whose presence would cause depression of the gene responsible for enzyme synthesis. Repression, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Sebastian Deindl, and Theresa A Kadlecek, and Tomas Brdicka, and Xiaoxian Cao, and Arthur Weiss, and John Kuriyan
October 2015, PLoS computational biology,
Sebastian Deindl, and Theresa A Kadlecek, and Tomas Brdicka, and Xiaoxian Cao, and Arthur Weiss, and John Kuriyan
September 1995, Nature,
Sebastian Deindl, and Theresa A Kadlecek, and Tomas Brdicka, and Xiaoxian Cao, and Arthur Weiss, and John Kuriyan
October 1999, Bioorganic & medicinal chemistry letters,
Sebastian Deindl, and Theresa A Kadlecek, and Tomas Brdicka, and Xiaoxian Cao, and Arthur Weiss, and John Kuriyan
May 1995, Immunity,
Sebastian Deindl, and Theresa A Kadlecek, and Tomas Brdicka, and Xiaoxian Cao, and Arthur Weiss, and John Kuriyan
March 2000, Biochemistry,
Sebastian Deindl, and Theresa A Kadlecek, and Tomas Brdicka, and Xiaoxian Cao, and Arthur Weiss, and John Kuriyan
November 1992, Cell,
Sebastian Deindl, and Theresa A Kadlecek, and Tomas Brdicka, and Xiaoxian Cao, and Arthur Weiss, and John Kuriyan
September 1998, The Journal of cell biology,
Sebastian Deindl, and Theresa A Kadlecek, and Tomas Brdicka, and Xiaoxian Cao, and Arthur Weiss, and John Kuriyan
October 1999, Journal of medicinal chemistry,
Sebastian Deindl, and Theresa A Kadlecek, and Tomas Brdicka, and Xiaoxian Cao, and Arthur Weiss, and John Kuriyan
June 1995, The EMBO journal,
Sebastian Deindl, and Theresa A Kadlecek, and Tomas Brdicka, and Xiaoxian Cao, and Arthur Weiss, and John Kuriyan
September 1996, The Journal of experimental medicine,
Copied contents to your clipboard!